港股异动 | 丹诺医药-B(06872)涨超7% 日前获纳入港股通名单利福喹酮IIa期概念验证数据积极

智通财经09-08

智通财经APP获悉，丹诺医药-B(06872)涨超7%，该股昨日曾冲高涨超15%，随后跳水收跌逾8%。截至发稿，涨7.45%，报165.8港元，成交额2741.28万港元。消息面上，9月7日起，丹诺医药正式获纳入港股通名单。公司表示，此次获纳入港股通，是资本市场对本公司投资价值、市值规模及流动性的全面认可。符合相关资格的中国内地投资者可通过沪深港通机制直接投资公司股票。丹诺医药专注于细菌感染及细菌...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2665340203?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-08 15:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2665340203","market":"sh","top_or_hot":-1,"title":"港股异动 | 丹诺医药-B(06872)涨超7% 日前获纳入港股通名单 利福喹酮IIa期概念验证数据积极","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，丹诺医药-B(06872)涨超7%，该股昨日曾冲高涨超15%，随后跳水收跌逾8%。截至发稿，涨7.45%，报165.8港元，成交额2741.28万港元。消息面上，9月7日起，丹诺医药正式获纳入港股通名单。公司表示，此次获纳入港股通，是资本市场对本公司投资价值、市值规模及流动性的全面认可。符合相关资格的中国内地投资者可通过沪深港通机制直接投资公司股票。丹诺医药专注于细菌感染及细菌...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1493266.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 丹诺医药-B(06872)涨超7% 日前获纳入港股通名单 利福喹酮IIa期概念验证数据积极</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 丹诺医药-B(06872)涨超7% 日前获纳入港股通名单 利福喹酮IIa期概念验证数据积极\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-08 15:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1493266.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，丹诺医药-B(06872)涨超7%，该股昨日曾冲高涨超15%，随后跳水收跌逾8%。截至发稿，涨7.45%，报165.8港元，成交额2741.28万港元。消息面上，9月7日起，丹诺医药正式获纳入港股通名单。公司表示，此次获纳入港股通，是资本市场对本公司投资价值、市值规模及流动性的全面认可。符合相关资格的中国内地投资者可通过沪深港通机制直接投资公司股票。丹诺医药专注于细菌感染及细菌...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1493266.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06872","symbol_name":"丹诺医药-B","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1493266.html","article_id":"2665340203","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2665340203","pubTimestamp":1788851053,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，丹诺医药-B涨超7%，该股昨日曾冲高涨超15%，随后跳水收跌逾8%。截至发稿，涨7.45%，报165.8港元，成交额2741.28万港元。消息面上，9月7日起，丹诺医药正式获纳入港股通名单。公司表示，此次获纳入港股通，是资本市场对本公司投资价值、市值规模及流动性的全面认可。丹诺医药专注于细菌感染及细菌代谢相关疾病领域。9月7日，丹诺医药公布，利福喹酮治疗人工关节感染的IIa期概念验证临床取得积极结果，多中心IIb期试验已启动。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06872":"丹诺医药-B","FLHK":"Franklin FTSE Hong Kong ETF","KCAI":"KraneShares China Alpha Index ETF","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","BK1161":"生物科技","BK4585":"ETF&股票定投概念"},"translate_title":"Hong Kong Stocks in Focus | Danno Pharma-B (06872) Rises Over 7% After Being Included in the Hong Kong Stock Connect List; Rifaquinone Phase IIa Proof-of-Concept Data Positive","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06872":1.5,"VXUS":1.5,"FLHK":1.5,"KCAI":1.5},"content_text":"智通财经APP获悉，丹诺医药-B(06872)涨超7%，该股昨日曾冲高涨超15%，随后跳水收跌逾8%。截至发稿，涨7.45%，报165.8港元，成交额2741.28万港元。消息面上，9月7日起，丹诺医药正式获纳入港股通名单。公司表示，此次获纳入港股通，是资本市场对本公司投资价值、市值规模及流动性的全面认可。符合相关资格的中国内地投资者可通过沪深港通机制直接投资公司股票。丹诺医药专注于细菌感染及细菌代谢相关疾病领域。公司依托自主开发的多靶点偶联分子技术平台，已建立7项创新管线，核心产品包括利福特尼唑（TNP-2198）和利福喹酮（TNP-2092注射剂）。9月7日，丹诺医药公布，利福喹酮治疗人工关节感染（PJI）的IIa期概念验证临床取得积极结果，多中心IIb期试验已启动。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2665340203","isCrawlerRequest":true}

港股异动 | 丹诺医药-B(06872)涨超7% 日前获纳入港股通名单 利福喹酮IIa期概念验证数据积极

精彩评论

港股异动 | 丹诺医药-B(06872)涨超7% 日前获纳入港股通名单利福喹酮IIa期概念验证数据积极